Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

NOVARTIS
FDA Approves Unknown Drug — NOVARTIS

This FDA approval from November 1983 represents a foundational milestone in Novartis's historical portfolio, though the current market impact is negli...

Hospira,
FDA Approves VITAMIN K1 — Hospira, Inc.

# FDA Approves Hospira's Phytonadione (Vitamin K1) for Intramuscular Injection Hospira, Inc. received FDA approval for phytonadione (Vitamin K1) inje...

GLAXOSMITHKLINE
FDA Approves Unknown Drug — GLAXOSMITHKLINE

# FDA Approves GlaxoSmithKline Drug (NDA 018342) GlaxoSmithKline has received FDA approval for a new drug application, marking an expansion of the co...

HOSPIRA
FDA Approves Unknown Drug — HOSPIRA

Hospira has obtained regulatory approval for a listed product application, signaling continued expansion of its pharmaceutical portfolio despite the f...

AbbVie
FDA Approves DEPAKOTE — AbbVie Inc.

# FDA Approval Newswire AbbVie Inc.'s DEPAKOTE (divalproex sodium) received FDA approval on March 10, 1983, establishing a foundational anticonvulsan...

Hikma
FDA Approves METHADONE HYDROCHLORIDE — Hikma Pharmaceuticals USA Inc.

# FDA Approves Methadone Hydrochloride Oral Formulation for Hikma Pharmaceuticals Hikma Pharmaceuticals USA Inc. received FDA approval for its oral m...

SUN
FDA Approves Unknown Drug — SUN PHARM INDUSTRIES

SUN PHARM INDUSTRIES announced FDA approval for ANDA087794, a regulatory milestone expected to bolster its product portfolio and support market share ...

STRIDES
FDA Approves Unknown Drug — STRIDES PHARMA

STRIDES PHARMA has obtained FDA approval for ANDA062337 on March 29, 1982, yet with a 1982 validation date and no associated brand or substance name l...

Marlex
FDA Approves FUROSEMIDE — Marlex Pharmaceuticals, Inc.

The FDA has confirmed the approval of Marlex Pharmaceuticals' oral furosemide product, supporting a staple in acute treatment protocols. While not a n...

PAI
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — PAI Holdings, LLC dba PAI Pharma

PAI Holdings, LLC dba PAI Pharma secured FDA approval for its Acetaminophen and Codeine Phosphate oral generic, strengthening the company’s position i...

PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT

Pharmobedient has announced approval for its ANDA submission, a milestone expected to drive market expansion for its generic product portfolio....

Hikma
FDA Approves METHADONE HYDROCHLORIDE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. announced this morning that the FDA approved a supplemental ANDA for Methadone Hydrochloride Oral Solution, a generic f...

ICU
FDA Approves RINGERS — ICU Medical, Inc.

# FDA Approves ICU Medical's Lactated Ringer's Solution, Expanding Critical Care Portfolio ICU Medical, Inc. has received FDA approval for Ringers (s...

HIKMA
FDA Approves Unknown Drug — HIKMA

HIKMA is positioned to bolster its market share following the FDA's approval of ANDA087003, a move expected to expand revenue streams as the generic e...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd received FDA approval for an Abbreviated New Drug Application, a milestone that is poised to enhance the company's m...

SUN
FDA Approves Unknown Drug — SUN PHARM INDS LTD

Sun Pharma Industries Ltd. obtained FDA approval for Abbreviated New Drug Application 085868, marking a key regulatory advancement for a new generic p...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS MID ATLANTIC

Actavis Mid Atlantic received FDA approval for a generic medication via ANDA #085861, strengthening its market position to capitalize on growth opport...

HIKMA
FDA Approves Unknown Drug — HIKMA

HIKMA announced the FDA approval of a **mitsubishiTanabe** manufactured injectable product under ANDA 085432. This new addition to the company's portf...

OZANTRI
FDA Approves Unknown Drug — OZANTRI

OZANTRI has solidified its market position in the pharmaceutical sector following the FDA's confirmation of its regulatory status via the benchmark AN...

Teva
FDA Approves PROGLYCEM — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. has confirmed the continued commercialization of the FDA-approved oral insulin secretion enhancer PROGLYCEM (diazoxide)...